Hostname: page-component-74656f9884-2dmjx Total loading time: 0 Render date: 2026-11-09T02:20:40.617Z Has data issue: false hasContentIssue false

Early-life nutritional programming of longevity

Published online by Cambridge University Press:  13 June 2014

A. M. Vaiserman*
Affiliation:
D.F. Chebotarev State Institute of Gerontology NAMS of Ukraine, Kiev, Ukraine
*
*Address for correspondence: A. M. Vaiserman, D.F. Chebotarev State Institute of Gerontology, Vyshgorodskaya st. 67, Kiev 04114, Ukraine. (Email vaiserman@geront.kiev.ua)
Rights & Permissions [Opens in a new window]

Abstract

Available data from both experimental and epidemiological studies suggest that inadequate diet in early life can permanently change the structure and function of specific organs or homoeostatic pathways, thereby ‘programming’ the individual’s health status and longevity. Sufficient evidence has accumulated showing significant impact of epigenetic regulation mechanisms in nutritional programming phenomenon. The essential role of early-life diet in the development of aging-related chronic diseases is well established and described in many scientific publications. However, the programming effects on lifespan have not been extensively reviewed systematically. The aim of the review is to provide a summary of research findings and theoretical explanations that indicate that longevity can be influenced by early nutrition.

Information

Type
Review
Copyright
© Cambridge University Press and the International Society for Developmental Origins of Health and Disease 2014 
Figure 0

Fig. 1 Schematic models of hypothetical mechanisms linking maternal undernutrition and overnutrition with adverse adult outcomes. (a) IUGR conditions caused by maternal undernutrition are associated with decreased levels of anabolic hormones (sex steroids, insulin, GH and IGF-1) along with the increased concentrations of catabolic hormones, such as glucocorticoids, higher apoptosis rate, and reprogramming of the HPA axis and GH/IGF axis during the fetal development. Such changes in the intrauterine growth-restricted fetus lead to low birth weight (<2.5 kg) and subsequent rapid catch-up growth, followed by higher risk for metabolic complications, including glucose intolerance, insulin resistance, hypertension and dyslipidemia, as well as T2D, CVD, NAFLD, osteoporosis and depressive disorder in adulthood. (b) LGA conditions, which are the result of excessive fetal growth caused by maternal overnutrition or gestational diabetes, are accompanied by upregulation of adipogenic genes, increased anabolic and decreased catabolic hormone levels, enhanced cell proliferation, increased adipocyte cell size and high activity of lipogenic enzymes. These conditions result in high birth weight (⩾4.0 kg), impaired development of the central appetite regulatory system, and a range of health problems including hyperinsulinemia and obesity, as well as several cancers, CVD and T2D in adulthood. IUGR, intrauterine growth restriction; GH, growth hormone; IGF-1, insulin-like growth factor-1; HPA, hypothalamic–pituitary–adrenal axis; T2D, type 2 diabetes; CVD, cardiovascular disease; NAFLD, non-alcoholic fatty liver disease; LGA, large-for-gestational age.